Biocompatibles has launched a new product in its CelLuminate range of
intracellular delivery systems The new CelLuminate VPS (Vesicle-forming
Polymer System) is made of from the company’s proprietary biomimetic
copolymer and is designed to improve the efficiency of intracellular
delivery of bioactive molecules compared to conventional liposomal systems.
Celuminate VPS can deliver a variety of molecules, including fluorophores,
RNA, DNA and proteins by exploiting natural cellular endocytotic pathways.
It is an order of magnitude faster than liposomal systems, according to the
company. The system is designed to allow researchers to prepare their own
vesicles to encapsulate any bioactive agent.
Established in 1984 with the focus of developing commercial applications in
the area of biocompatibility - the ability of a material to interface within
the body without provoking an adverse biological response, Biocompatibles
International plc is now a leading medical technology and life science